医学
黑色素瘤
皮肤病科
转移性黑色素瘤
免疫疗法
威罗菲尼
肿瘤科
内科学
癌症研究
癌症
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2020-07-22
卷期号:156 (11): 1177-1177
被引量:16
标识
DOI:10.1001/jamadermatol.2020.2398
摘要
The effectiveness of immune checkpoint inhibitors (ICIs) and BRAF and MEK inhibitors has improved advanced melanoma recovery. However, it is unknown whether these novel therapies are cost-effective for newly diagnosed advanced melanoma with unknown BRAF status.
科研通智能强力驱动
Strongly Powered by AbleSci AI